Comparison
Eloralintide vs. Pramlintid
Two peptides side-by-side — identity, evidence base, legal status and known adverse events.
Identity
Category
Metabolic
Metabolic
CAS no.
no data
151126-32-8
Molecular weight
no data
3949.4 g/mol
Half-life
no data
no data
Sequence
no data
no data
Mechanism of action
Eloralintide
Eloralintide selectively activates amylin receptors (preferentially AMY1R) and promotes satiety. The approach targets weight loss via the amylin axis, complementary to or independent of GLP-1 agents.
Pramlintid
Pramlintide mimics the beta-cell hormone amylin, which is co-secreted with insulin. It slows gastric emptying, suppresses postprandial glucagon release and promotes satiety — thereby blunting post-meal blood-glucose spikes.
Evidence base
Highest evidence
Human RCT
Human RCT
Studies
2
0
of which in humans
1
0
Effects recorded
2
2
Open conflicts
0
1
Documented adverse events
1
2
Legal status
Full entries
Frequently asked questions
- What is the difference between Eloralintide and Pramlintid?
- Eloralintide is classified as "Metabolic", while Pramlintid is classified as "Metabolic". Eloralintide: Eloralintide is a selective, long-acting amylin receptor agonist from Eli Lilly for once-weekly subcutaneous use — under investigation for obesity, alone and combined with incretin therapy. Pramlintid: Pramlintide is a synthetic analog of the hormone amylin. It is used as an adjunct to mealtime insulin therapy in type 1 and type 2 diabetes and, among other things, slows gastric emptying. This page contrasts both neutrally and source-based — with no usage or dosing recommendation.
- Which peptide is better supported by science, Eloralintide or Pramlintid?
- The highest available evidence level is "Human RCT" for Eloralintide and "Human RCT" for Pramlintid. A higher evidence level means more robust data, but says nothing about suitability for an individual. The full body of evidence is on each peptide's own page.
- What is the legal status of Eloralintide and Pramlintid in Germany and the United States?
- Germany: Eloralintide — Unapproved, Pramlintid — Unapproved. United States: Eloralintide — Unapproved, Pramlintid — Prescription. These are factual summaries with source and review date on the individual pages.